Shock: all 921 studies

Page 7 of 10. Open to participants first (171), then studies with results posted, then the rest; newest registration first within each.

• The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock TrialCompletedNCT03333278Phase 2
• Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMOCompletedNCT03327493Not applicable
• Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal PeriodTerminatedNCT03311178Phase 1/2
• Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock PatientsStatus unknownNCT03308227
• The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock PatientsCompletedNCT03308214
• Angiotensin II for Septic Shock TreatmentSuspendedNCT03302650Phase 3
• Innate Lymphoid Cells in Septic ShockCompletedNCT03297203Not applicable
• Point of Care Ultrasonography In The Management of Shock: A Pilot StudyCompletedNCT03296891Not applicable
• Extension of the RUSH Protocol for Volume ResponsivenessWithdrawnNCT03285269
• Hemodynamic Assessment in Cardiogenic Shock Regarding the EtiologyStatus unknownNCT03283995
• The Impact of Point-of-Care UltrasoundCompletedNCT03276364
• Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic ShockCompletedNCT03258619
• Expanded Access for LJPC-501Approved for marketingNCT03245528
• The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric StonesStatus unknownNCT03243682Not applicable
• Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic ShockStatus unknownNCT03235921Phase 2
• Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICUCompletedNCT03225378
• EFFECTS OF SHOCK WAVE THERAPY IN WOMEN WITH PAIN IN TRAPÉZIO MUSCLECompletedNCT03222154Not applicable
• Effects of Blood Flow of Venoarterial Extracorporeal Membrane Oxygenation Life Support on MicrocirculationCompletedNCT03210818
• Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2Status unknownNCT03208257Phase 2
• Reversibility of Diastolic Disfunction in Septic ShockStatus unknownNCT03198611
• Neuromuscular Electrical Stimulation and Septic ShockSuspendedNCT03193164Not applicable
• Variation in Fluids Administered in ShockCompletedNCT03190408
• Crystalloids for AKI in Shock PatientsStatus unknownNCT03188614Not applicable
• A Systematic Echography During Intubation Procedure to Predict Cardiovascular CollapseCompletedNCT03184207
• Different Crystalloids on AKI in ShockStatus unknownNCT03155126
• Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock PatientsStatus unknownNCT03151668Phase 3
• Restrictive Intravenous Fluids Trial in SepsisCompletedNCT03137446Not applicable
• Candida Host Defense Response After Septic Shock in the Critically IllCompletedNCT03136081
• Thiamine Supplementation in Patients With Septic ShockWithdrawnNCT03122678Phase 1
• Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene BlueCompletedNCT03120637Phase 4
• Proadrenomedullin and Copeptin in Patients With Septic ShockCompletedNCT03104933
• Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic ShockCompletedNCT03104140Phase 3
• Airway Collapse in Patients With Mounier-Kuhn Syndrome: Titration With Positive Pressure to Reduce CollapseStatus unknownNCT03101059Not applicable
• Critical Care Ultrasound Oriented Shock Treatment in ICUCompletedNCT03093987Not applicable
• Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) TrialCompletedNCT03092245Phase 2
• Effects of Nursing Staff on Empiric Antibiotic in Septic ShockCompletedNCT03085459
• The CCUS Based Characteristic of Hemodynamic and Lung Pathology in Early Stage of Shock in ICU: The Epidemic and Prognostic ValueCompletedNCT03082326
• SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual CareCompletedNCT03080038Not applicable
• Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK StudyCompletedNCT03078712Not applicable
• Accuracy of Pulse Pressure Variations Measured by a Non Invasive Digital Device to Predict Fluid ResponsivenessTerminatedNCT03066388Not applicable
• Respiratory Variations For Predicting Fluid Responsiveness 2CompletedNCT03066375Not applicable
• Respiratory Variations for Predicting Fluid ResponsivenessCompletedNCT03066362Not applicable
• Plasmaexchange in Early Septic ShockStatus unknownNCT03065751Not applicable
• BWH Critical Care Study of CareGuide for Evaluation of Emerging or Established ShockStatus unknownNCT03060369
• Diagnostic Investigation and Prediction of ShockCompletedNCT03043170
• What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or TerlipressinStatus unknownNCT03038503Phase 3
• Propafenone Versus Amiodarone in Septic ShockCompletedNCT03029169Phase 4
• Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic ShockCompletedNCT03014063
• Influence of Fluid Challenge on End-Expiratory Lung Impedance in Mechanically Ventilated Patients Monitored With Electrical Impedance TomographyCompletedNCT02992002
• Midodrine in the Recovery Phase of Septic ShockWithdrawnNCT02990546Phase 3
• Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic ShockStatus unknownNCT02985008
• Diagnostic Performance of Echocardiography Performed by Emergency Physicians After a Basic TrainingTerminatedNCT02974790
• Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic ShockStatus unknownNCT02972827Not applicable
• Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic ShockStatus unknownNCT02963454Not applicable
• Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic ShockStatus unknownNCT02962700Not applicable
• Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney InjuryStatus unknownNCT02937961Not applicable
• Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of HemolysisCompletedNCT02924792
• Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic DysfunctionCompletedNCT02899897
• Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in ChildrenWithdrawnNCT02899702Phase 4
• Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein CCompletedNCT02885168Phase 4
• Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid TestStatus unknownNCT02878369
• Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic ShockCompletedNCT02876341
• Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)TerminatedNCT02875236Phase 4
• The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock PatientsStatus unknownNCT02870946Not applicable
• GapCO2 and Respiratory Rate in Patients Under Volume Mechanical VentilationStatus unknownNCT02867943
• Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive CareCompletedNCT02856191Not applicable
• Satisfaction of Patient With Anaphylaxis in the Use of a Medical DeviceCompletedNCT02854969Not applicable
• Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock PatientsStatus unknownNCT02842983Phase 2/3
• Balanced Crystalloid vs. Saline in Children With Septic ShockCompletedNCT02835157Not applicable
• PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockCompletedNCT02820987Phase 3
• Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)Status unknownNCT02803346
• Registry for Cardiogenic Shock: Utility and Efficacy of Device TherapyTerminatedNCT02790242
• A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock ResuscitationStatus unknownNCT02782819Not applicable
• Observational Study on Intubation in Septic ShockCompletedNCT02780466
• Evaluation of Resuscitation Markers in Trauma PatientsCompletedNCT02772653
• Midodrine During Recovery From Septic ShockWithdrawnNCT02771158Phase 4
• Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.CompletedNCT02768740Phase 4
• Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway PressureCompletedNCT02763631Not applicable
• Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)CompletedNCT02754193Not applicable
• Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic ShockCompletedNCT02750683
• Fluids in Sepsis and Septic ShockCompletedNCT02748382Phase 2/3
• Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)CompletedNCT02736812Phase 3
• Optimized Caloric-proteic Nutrition in Septic and Septic Shock PatientsTerminatedNCT02731144Phase 4
• Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic ShockCompletedNCT02730624Phase 4
• Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary ThermodilutionCompletedNCT02728791
• Suspension SyndromeCompletedNCT02726776Not applicable
• Effect of Albumin Administration on Vasopressor Duration in Resolving Septic ShockTerminatedNCT02716597Phase 1
• French Observatory on the Management of Cardiogenic Shock in 2016CompletedNCT02703038
• Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological MarkersStatus unknownNCT02692053Not applicable
• Circulating microRNAs in Patients With STEMI Complicated With Cardiogenic ShockStatus unknownNCT02691286
• Study the Impact of Statins in Septic ShockCompletedNCT02681653Not applicable
• Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler ExaminationStatus unknownNCT02676427
• Kinetics of the Sublingual Microcirculation During Fluid BolusCompletedNCT02675725
• Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in ShockTerminatedNCT02666404Not applicable
• Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.CompletedNCT02655133Phase 2
• Strong Ion Gap as Prognostic Indicator for Adult Patients Admitted With Shock to the Intensive Care UnitsCompletedNCT02652364
• Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in ChinaCompletedNCT02647554Phase 4
• Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic ShockStatus unknownNCT02640846Phase 4
• Hemodynamic Effects of Dexmedetomidine in Septic ShockCompletedNCT02638545Phase 3
• Early Goal Directed Sedation on Microcirculation in Septic ShockStatus unknownNCT02612363Phase 4

← Shock overview